Tedros Adhanom Ghebreyesus & Serum Institute of India

Tedros Adhanom Ghebreyesus: As Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus has emphasized the importance of a Bundibugyo vaccine for controlling the current epidemic and strengthening preparedness.

Serum Institute of India: The Serum Institute of India is fast-tracking the development and production of a vaccine candidate for the Bundibugyo strain of Ebola, positioning itself as a key player in global health security and potentially increasing its market value and reputation.

Tedros Adhanom Ghebreyesus: Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, has been instrumental in declaring the public health emergency and communicating the escalating risk of the Ebola outbreak.

Serum Institute of India: The Serum Institute of India is manufacturing a vaccine candidate developed by the University of Oxford, receiving up to $8.6 million from CEPI for its development.

Tedros Adhanom Ghebreyesus: Tedros Adhanom Ghebreyesus>>>, the Director-General of the World Health Organization>>>, has declared the Ebola outbreak a public health emergency of international concern and is actively involved in coordinating the response, visiting affected areas and urging international action.

Serum Institute of India: The Serum Institute of India is manufacturing doses of a vaccine candidate built on the University of Oxford/AstraZeneca platform, which could be used for clinical trials against the Bundibugyo ebolavirus.